ILMN
33
-9
EIX
45
-5
STI
1
-24
RCL
55
-2
TXT
65
-4
BEN
37
-3
KMX
36
-11
HOG
29
-4
HST
55
-3
WFC
65
2
BXP
36
-8
BDX
36
-10
WY
51
-3
VNO
61
-7
MA
55
-2
UNP
39
-3
AIG
44
-3
EXC
58
-2
URBN
50
-10
WHR
33
-3
ILMN
33
-9
EIX
45
-5
STI
1
-24
RCL
55
-2
TXT
65
-4
BEN
37
-3
KMX
36
-11
HOG
29
-4
HST
55
-3
WFC
65
2
BXP
36
-8
BDX
36
-10
WY
51
-3
VNO
61
-7
MA
55
-2
UNP
39
-3
AIG
44
-3
EXC
58
-2
URBN
50
-10
WHR
33
-3
Financhill
Back

Voyager Therapeutics Quote, Financials, Valuation and Earnings

Will Crypto Make People Rich Again Starting April 2024?

Details on how to profit here.
Sell
44

VYGR
Voyager Therapeutics

Last Price:
8.03
Seasonality Move:
7.86%

7 Day Trial

ALL ACCESS PASS

$ 7

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.

Voyager Therapeutics Price Quote

$8.03
-0.22 (-2.67%)
(Updated: April 16, 2024 at 2:35 PM ET)

Voyager Therapeutics Key Stats

Sell
44
Voyager Therapeutics (VYGR) is a Sell
Day range:
$8.13 - $8.45
52-week range:
$6.06 - $14.34
Dividend yield:
0%
P/E ratio:
2.78
P/S ratio:
1.48
P/B ratio:
1.9%
Volume:
389K
Avg. volume:
773K
1-year change:
2.23%
Market cap:
$448M
Revenue:
$250M
EPS:
$3.03

How Much Does Voyager Therapeutics Make?

Is Voyager Therapeutics Growing As A Company?

Data Unavailable

Voyager Therapeutics Stock Price Performance

What Is Voyager Therapeutics 52-Week High & Low?

Voyager Therapeutics Price To Free Cash Flow

Is It Risky To Buy Voyager Therapeutics?

Is Voyager Therapeutics Cash Flow Positive?

  • What Is VYGR Cash Flow From Operations?
    Cash flow from operations (TTM) is $77.9M
  • What Is Voyager Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $33.6M
  • What Is Voyager Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$141.6M

Voyager Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VYGR return on invested capital is 74.55%
  • What Is Voyager Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 45.41%
  • What Is VYGR Return On Equity?
    ROE is a measure of profitability and is 74.55%

Voyager Therapeutics Earnings Date & Stock Price

Voyager Therapeutics Competitors

Voyager Therapeutics Dividend Yield

Data Unavailable

Voyager Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 881.25%
Revenue: 0% 336.4%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 17.78
Upside from Last Price: 115.49%

Major Shareholders

  • How many VYGR shares are owned by institutional investors?
    48.2M VYGR shares are owned by institutional investors
  • How many VYGR shares are owned by insiders?
    2.8M VYGR shares are owned by insiders